Bijuva 1 mg / 100 mg, capsule molle

7680689710013 CH-68971 capsule molle
Bijuva 1 mg / 100 mg, capsule molle
Bijuva 1 mg / 100 mg, capsule molle
Bijuva 1 mg / 100 mg, capsule molle
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Kapsel(n)
Galenic form
capsule molle
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/09/2025
Patient information leaflet
Français
03/09/2025
Patient information leaflet
Italien
03/09/2025
Summary of Product Characteristics
Allemand
03/09/2025
Summary of Product Characteristics
Français
03/09/2025
Summary of Product Characteristics
Italien
03/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 16.55
Specialties list
Yes
Generic
No
SL addition date: 01/06/2025

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
68971
Drug name
Bijuva, capsule molle
Galenic form
KAPWE
ATC Code
G03FA04
Authorization status
Z
Dispensing category
B
First authorization
04/04/2024
Authorization expiration date
03/04/2029
IT Number
07.08.6.
Domain
Human medicine
Field of application
Postmenopausale Hormonsubstitutionstherapie

Package details

Description (FR)
BIJUVA caps moll 1 mg/100 mg 28 pce
Description (DE)
BIJUVA Weichkaps 1 mg/100 mg 28 Stk
Market launch
04/04/2024
Narcotic (BTM)
No